Incidence and Management of Posttransplantation Lymphoproliferative Disorder After Pediatric Solid Organ Transplantation: The Norwegian Experience

Documenti analoghi

• Transfer of Aging: Implications for Pediatric Solid Organ Transplantation
  di: Rosalie Wolff von Gudenberg, et al.
  Pubblicazione: (2025)
• Drug Usage and Risk for Polypharmacy After Pediatric Solid Organ Transplantation—A National Register Study
  di: Rebekka Salonen, et al.
  Pubblicazione: (2025)
• Pneumocystis jiroveci Pneumonia Infections in Pediatric Solid Organ Transplant Recipients
  di: Emily A. Hayes, et al.
  Pubblicazione: (2025)
• Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant
  di: Mario M. Landa, et al.
  Pubblicazione: (2025)
• Ionizing Radiation Exposure From Imaging in Pediatric Solid Organ Transplant Recipients
  di: Cal H. Robinson, et al.
  Pubblicazione: (2026)